Laparoscopic Therapy of Endometrioma: Sclerotherapy vs Cystectomy in Patients With Unfinished Reproductive Plans

Launched by INSTITUTE FOR THE CARE OF MOTHER AND CHILD, PRAGUE, CZECH REPUBLIC · Apr 5, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at two different surgical methods to treat endometriomas, which are cysts caused by endometriosis. The researchers want to see whether laparoscopic sclerotherapy (a procedure that uses a special solution to shrink the cyst) or cystectomy (surgery to remove the cyst) is better for women who still want to have children in the future. They will be measuring things like how the treatments affect hormone levels, how often the cysts come back, any complications from the surgeries, and the chances of getting pregnant afterwards.

To be eligible for the trial, participants need to be women aged 18 to 40 with endometriomas that are at least 30 mm wide and have plans to have children in the future. Women with certain conditions, like previous endometriomas that came back, signs of cancer, or other pelvic diseases, cannot participate. Those who join can expect close monitoring and support throughout the study, as well as a chance to contribute to important research that may help others facing similar challenges.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • IOTA benign endometrioma
• • bilateral or unilateral endometrioma measuring 30 or more milimeters
• • patients with unfinished reproductive plans
• Exclusion Criteria:
• • bilateral recurrence of endometrioma
• • recurrent endometrioma if the other ovary is not present or patient had cystectomy on the other ovary
• • suspision for ovarian malignancy
• • signs of inflammatory pelvic disease
• • disagreement with participation in the study